209 related articles for article (PubMed ID: 30008892)
1. Histone deacetylase inhibitors induce the expression of tumor suppressor genes Per1 and Per2 in human gastric cancer cells.
Hernández-Rosas F; Hernández-Oliveras A; Flores-Peredo L; Rodríguez G; Zarain-Herzberg Á; Caba M; Santiago-García J
Oncol Lett; 2018 Aug; 16(2):1981-1990. PubMed ID: 30008892
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors promote the expression of ATP2A3 gene in breast cancer cell lines.
Contreras-Leal E; Hernández-Oliveras A; Flores-Peredo L; Zarain-Herzberg Á; Santiago-García J
Mol Carcinog; 2016 Oct; 55(10):1477-85. PubMed ID: 26331238
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors promote ATP2A3 gene expression in hepatocellular carcinoma cells: p300 as a transcriptional regulator.
Hernández-Oliveras A; Izquierdo-Torres E; Meneses-Morales I; Rodríguez G; Zarain-Herzberg Á; Santiago-García J
Int J Biochem Cell Biol; 2019 Aug; 113():8-16. PubMed ID: 31146004
[TBL] [Abstract][Full Text] [Related]
4. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
5. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
Meng CF; Zhu XJ; Peng G; Dai DQ
Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
[TBL] [Abstract][Full Text] [Related]
6. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways.
Hrgovic I; Doll M; Kleemann J; Wang XF; Zoeller N; Pinter A; Kippenberger S; Kaufmann R; Meissner M
BMC Cancer; 2016 Sep; 16(1):763. PubMed ID: 27716272
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression.
Young DA; Billingham O; Sampieri CL; Edwards DR; Clark IM
FEBS J; 2005 Apr; 272(8):1912-26. PubMed ID: 15819885
[TBL] [Abstract][Full Text] [Related]
8. Temporal orchestration of repressive chromatin modifiers by circadian clock Period complexes.
Duong HA; Weitz CJ
Nat Struct Mol Biol; 2014 Feb; 21(2):126-32. PubMed ID: 24413057
[TBL] [Abstract][Full Text] [Related]
9. Circadian time-dependent tumor suppressor function of period genes.
Yang X; Wood PA; Ansell C; Hrushesky WJ
Integr Cancer Ther; 2009 Dec; 8(4):309-16. PubMed ID: 19926612
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of Per1, Per2 and Per3 and their prognostic relevance in non-small cell lung cancer.
Liu B; Xu K; Jiang Y; Li X
Int J Clin Exp Pathol; 2014; 7(11):7863-71. PubMed ID: 25550826
[TBL] [Abstract][Full Text] [Related]
11. Differential patterns in the periodicity and dynamics of clock gene expression in mouse liver and stomach.
Mazzoccoli G; Francavilla M; Pazienza V; Benegiamo G; Piepoli A; Vinciguerra M; Giuliani F; Yamamoto T; Takumi T
Chronobiol Int; 2012 Dec; 29(10):1300-11. PubMed ID: 23131081
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
[TBL] [Abstract][Full Text] [Related]
13. Differential activation of the IGF binding protein-3 promoter by butyrate in prostate cancer cells.
Tsubaki J; Hwa V; Twigg SM; Rosenfeld RG
Endocrinology; 2002 May; 143(5):1778-88. PubMed ID: 11956160
[TBL] [Abstract][Full Text] [Related]
14. Circadian and light-induced transcription of clock gene Per1 depends on histone acetylation and deacetylation.
Naruse Y; Oh-hashi K; Iijima N; Naruse M; Yoshioka H; Tanaka M
Mol Cell Biol; 2004 Jul; 24(14):6278-87. PubMed ID: 15226430
[TBL] [Abstract][Full Text] [Related]
15. PER1 as a Tumor Suppressor Attenuated in the Malignant Phenotypes of Breast Cancer Cells.
Liu Y; Hao J; Yuan G; Wei M; Bu Y; Jin T; Ma L
Int J Gen Med; 2021; 14():7077-7087. PubMed ID: 34712059
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation in circadian genes of endometrial cancers detected by methylation-specific PCR.
Shih MC; Yeh KT; Tang KP; Chen JC; Chang JG
Mol Carcinog; 2006 Oct; 45(10):732-40. PubMed ID: 16683245
[TBL] [Abstract][Full Text] [Related]
17. Prognostic relevance of Period1 (Per1) and Period2 (Per2) expression in human gastric cancer.
Zhao H; Zeng ZL; Yang J; Jin Y; Qiu MZ; Hu XY; Han J; Liu KY; Liao JW; Xu RH; Zou QF
Int J Clin Exp Pathol; 2014; 7(2):619-30. PubMed ID: 24551282
[TBL] [Abstract][Full Text] [Related]
18. Low circadian clock genes expression in cancers: A meta-analysis of its association with clinicopathological features and prognosis.
Zhang J; Lv H; Ji M; Wang Z; Wu W
PLoS One; 2020; 15(5):e0233508. PubMed ID: 32437452
[TBL] [Abstract][Full Text] [Related]
19. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers.
Chen ST; Choo KB; Hou MF; Yeh KT; Kuo SJ; Chang JG
Carcinogenesis; 2005 Jul; 26(7):1241-6. PubMed ID: 15790588
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.
Camarero N; Nadal A; Barrero MJ; Haro D; Marrero PF
Nucleic Acids Res; 2003 Mar; 31(6):1693-703. PubMed ID: 12626711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
